✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic PolicyRegulationMedical CannabisResearchClinical Practice Why This MattersCannabis reclassification from Schedule I to Schedule III would...
In the Mix: 10 More Articles — March 19, 2026
In the Mix — Last 24 HoursMarch 19, 2026. 10 articles reviewed below the CED clinical relevance threshold of 35. Listed in descending order of score. #25CCB Deputy Director Miles Appointed Acting...
Federal CBD Health Insurance Plan Will Reportedly Allow THC Amount Far … – Marijuana Moment
✦ New CED Clinical Relevance #65 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyCBDTHCDosingSafety Why This Matters Clinicians need to understand that federal insurance coverage for CBD with...
Lowcountry hemp sellers plan lawsuit after DEA seizes products and cash in raids – WCIV
✦ New CED Clinical Relevance #35 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyHempTHCIndustry Clinical Summary The Drug Enforcement Administration conducted raids on multiple low-country hemp retailers, seizing...
Congressional Researchers Give Update On Marijuana Rescheduling And Upcoming Hemp …
✦ New CED Clinical Relevance #65 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyResearchHemp Clinical Summary # Clinical Summary Congressional research indicates ongoing deliberation regarding marijuana rescheduling at...
Feds keep marijuana tests for workers despite Trump reclassification order – Yahoo
✦ New CED Clinical Relevance #62 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyIndustrySafety Why This Matters Federal workplace drug testing policies that continue screening for marijuana metabolites...
FDA Submits New Cannabis Products Enforcement Policy For White House Review
✦ New CED Clinical Relevance #55 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyResearchSafetyIndustry Clinical Summary The FDA has submitted a new enforcement policy regarding cannabis products to...
Pa. Senate body amends cannabis bill to include stricter federal standards on hemp
✦ New CED Clinical Relevance #55 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyHempResearchSafety Why This Matters Clinicians need to understand that Pennsylvania's adoption of stricter federal hemp...
With Marijuana Rescheduling Still Pending, Federal Workplace Drug Testing Rules Aren’t …
✦ New CED Clinical Relevance #45 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyResearchIndustry Why This Matters # Why This Matters for CliniciansClinicians need to understand current federal...
U.S. Farm Bill revisions would modestly reshape rules for fiber and grain growers
✦ New CED Clinical Relevance #35 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyHempIndustry Why This Matters # Clinical Relevance StatementClarifying regulatory boundaries between industrial hemp and cannabinoid...